Sachdev Amit's Form 4 filing
Vertex Pharmaceuticals Inc (VRTX) · filed Aug 14, 2023
- Accession no.
- 0000899243-23-018109
- Filed
- Aug 14, 2023
- Trade date
- Aug 10, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $3.51M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sachdev AmitCIK 0001406338 | Officer (EVP, Chief Patient Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 10, 2023 | Common Stock | SSaleDisposed | −10,031 | $350.00 | −$3,510,850 | 58,814 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.